Biosynex Nordic ApS: Financial statements 2023
CVR: 38417541
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178. The company had 3 employees in the financial year.
- Gross Profit
- DKK -1,062,001
- Profit/Loss
- DKK -3,931,794
- Equity
- DKK -3,814,178
- Total Assets
- DKK 3,486,914
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -1.1M | -3.9M | -3.8M | 3 |
| 2022 | - | 52.1M | 41.8M | 118K | 2 |
| 2021 | - | 65.4M | 49.7M | 40.1M | 1 |
| 2020 | - | 5.1M | 4M | 4.2M | 0 |
| 2019 | - | 231K | 178K | 199K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 17, 2023, Jacques Cavadenti has left the board of directors of Biosynex Nordic ApS.
Biosynex Nordic ApS has published its annual report for 2022. Gross profit came to DKK 52,128,274, and the net result was DKK 41,802,660.
On January 9, 2023, the company changed its name from Medkoncept A/S to Biosynex Nordic A/S.
About Biosynex Nordic ApS
Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.